Imago Biosciences is a privately-held biotechnology company focused on translating the science of genetics and epigenetics into products that address specific patient needs.

We are funded by Clarus Ventures, Frazier Healthcare Partners, Amgen Ventures, and MRL Ventures Fund along with strategic investors, who are committed to helping us advance our research and development programs while adding value each step of the way.


Imago has a team of dedicated professionals who have proven their ability to advance product development in an effective, thoughtful and efficient manner. This, along with its exciting research in areas of unmet need, is what makes Imago a compelling investment opportunity.

Dennis Henner
Clarus Ventures